Proxy Votes Now

Home › Funds › Equitable › 1290 VT Equity Income Portfolio

1290 VT Equity Income Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000009044

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 603 with, 34 against, 1 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 10 FOR, 24 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)93.6%58092.5%339,726
Backed environmental and social shareholder proposals at US companiesn/a209.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 29 items (8.3% of the 351 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Merck & Co., Inc.2026-05-26Shareholder Shareholder proposal regarding a report on DEI risks in federal contracting.ForAGAINST — 25 of 25 Equitable fundsAgainstFailed (calculated), 1.2% support
Merck & Co., Inc.2026-05-26Shareholder Shareholder proposal regarding a report on healthcare coverage gaps.ForAGAINST — 25 of 25 Equitable fundsAgainstFailed (calculated), 1.3% support
The Charles Schwab Corporation2026-05-21Election of directors for three-year terms: Marianne C. BrownAgainstFOR — 23 of 23 Equitable fundsAgainstElected, 98.0% support
UnitedHealth Group Incorporated2026-06-01Shareholder If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent.ForAGAINST — 21 of 21 Equitable fundsAgainstNot approved, 20.3% support
UnitedHealth Group Incorporated2026-06-01Advisory approval of the Company's executive compensation.AgainstFOR — 21 of 21 Equitable fundsAgainstApproved, 82.6% support
Microchip Technology Incorporated2025-08-19Election of Directors: Steve SanghiAgainstFOR — 21 of 21 Equitable fundsAgainstElected, 91.9% support
Hewlett Packard Enterprise Company2026-04-01Election of Directors: Bethany J. MayerAgainstFOR — 20 of 20 Equitable fundsAgainstPassed (calculated), 97.0% support
Hewlett Packard Enterprise Company2026-04-01Election of Directors: Frank A. D'AmelioAgainstFOR — 20 of 20 Equitable fundsAgainstPassed (calculated), 98.2% support
Hewlett Packard Enterprise Company2026-04-01Election of Directors: Patricia F. RussoAgainstFOR — 20 of 20 Equitable fundsAgainstPassed (calculated), 95.2% support
Xcel Energy Inc.2026-05-20Approval of Xcel Energy Inc.'s executive compensation in an advisory vote (say on pay vote)AgainstFOR — 20 of 20 Equitable fundsAgainstPassed (calculated), 90.5% support
Everest Group, Ltd.2026-05-13Election of Directors for a term to end in 2027: Laura HayAgainstFOR — 20 of 20 Equitable fundsAgainstPassed (calculated), 96.4% support
Philip Morris International Inc.2026-05-06Election of Directors: Lisa A. HookAgainstFOR — 18 of 18 Equitable fundsAgainstElected, 97.5% support
Wells Fargo & Company2026-04-28Election of Directors: Suzanne M. VautrinotAgainstFOR — 18 of 18 Equitable fundsAgainstElected, 98.2% support
Wells Fargo & Company2026-04-28Election of Directors: Wayne M. HewettAgainstFOR — 18 of 18 Equitable fundsAgainstElected, 93.9% support
General Dynamics Corporation2026-05-06Election of Directors: Cecil D. HaneyAgainstFOR — 17 of 17 Equitable fundsAgainstElected, 91.7% support
International Flavors & Fragrances Inc.2026-04-29Approve, on an advisory basis, the compensation of our named executive officers in 2025.AgainstFOR — 18 of 18 Equitable fundsAgainstPassed (calculated), 87.3% support
Fidelity National Information Services, Inc.2026-06-10Election of Directors: Lisa A. HookAgainstFOR — 18 of 18 Equitable fundsAgainstElected, 97.4% support
Tyson Foods, Inc.2026-02-05Shareholder Shareholder proposal regarding report on the anticipated impact of recent changes in US immigration practices on the Company's finances and operations.ForAGAINST — 16 of 16 Equitable fundsAgainstFailed (calculated), 2.7% support
Tyson Foods, Inc.2026-02-05Election of Directors: Olivia L. TysonAgainstFOR — 14 of 16 Equitable fundsAgainstPassed (calculated), 91.7% support
Tyson Foods, Inc.2026-02-05Election of Directors: Les R. BaledgeForAGAINST — 13 of 16 Equitable fundsForPassed (calculated), 95.0% support
Humana Inc.2026-04-16Election of Directors: Wayne A. I. Frederick, M.D.ForAGAINST — 14 of 19 Equitable fundsForElected, 83.4% support
Public Storage2026-05-06Election of Trustees: Shankh S. MitraForAGAINST — 13 of 21 Equitable fundsForPassed (calculated), 75.8% support
Oracle Corporation2025-11-18Advisory Vote to Approve the Compensation of our Named Executive OfficersForAGAINST — 15 of 26 Equitable fundsForPassed (calculated), 81.9% support
Everest Group, Ltd.2026-05-13To approve, by non-binding advisory vote, 2025 compensation paid to the Company's Named Executive Officers.ForAGAINST — 11 of 19 Equitable fundsForPassed (calculated), 92.0% support
GE HealthCare Technologies Inc.2026-05-07Election of Directors: Kevin A. LoboAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 91.2% support
Show all 29
Items 26 to 29.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Humana Inc.2026-04-16Shareholder The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting.AgainstFOR — 9 of 16 Equitable fundsForNot approved, 41.5% support
Tyson Foods, Inc.2026-02-05Shareholder Shareholder proposal regarding report on environmental and human health impacts from waste lagoons.ForAGAINST — 8 of 15 Equitable fundsAgainstFailed (calculated), 2.5% support
Tyson Foods, Inc.2026-02-05Election of Directors: Barbara A. TysonAgainstFOR — 8 of 15 Equitable fundsAgainstPassed (calculated), 95.2% support
Tyson Foods, Inc.2026-02-05Election of Directors: Noel WhiteAgainstFOR — 8 of 15 Equitable fundsAgainstPassed (calculated), 97.6% support

Download all 29 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 84.8% of this fund’s 638 such votes could be given a sector; the other 97 (15.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance110109.1%
Health Care8766.9%
Industrials8211.2%
Utilities5300.0%
Energy4436.8%
Consumer Discretionary4112.4%
Technology3912.6%
Real Estate3800.0%
Consumer Staples21314.3%
Telecommunications1417.1%
Basic Materials1200.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections4420
Audit-related460
Say-on-Pay390
Compensation312
Corporate Governance2810
Capital Structure240
Environment or Climate88
Other Social Issues86
Shareholder Rights and Defenses72
Human Rights or Human Capital/workforce44

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
DuPont de Nemours, Inc.May 21, 2026$40M140
Merck & Co., Inc.May 26, 2026$22M183
Humana Inc.April 16, 2026$20M141
Phillips 66May 13, 2026$20M60
Chevron CorporationMay 27, 2026$19M173
Plains GP Holdings, L.P.May 20, 2026$17M60
Air Products and Chemicals, Inc.January 28, 2026$16M120
Public StorageMay 6, 2026$16M140

Notable votes against management

MeetingCompanyProposalFundMgmt
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalForAgainst
April 16, 2026Humana Inc.The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. Shareholder proposalAgainstFor
May 27, 2026Chevron CorporationAdopt an Independent Chair Shareholder proposalAgainstFor
May 27, 2026Chevron CorporationReport on Indigenous Peoples Rights Shareholder proposalAgainstFor
May 19, 2026JPMorgan Chase & Co.Report on congruence of security, resiliency, and climate initiatives Shareholder proposalAgainstFor
May 19, 2026JPMorgan Chase & Co.Independent board chairman Shareholder proposalAgainstFor
April 1, 2026Hewlett Packard Enterprise CompanyStockholder proposal entitled: "Report on Discrimination in Charitable Support." Shareholder proposalAgainstFor
May 6, 2026Philip Morris International Inc.Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposalAgainstFor
April 14, 2026The Bank of Nova ScotiaShareholder Proposal Regarding Participation in Annual Meetings Shareholder proposalAgainstFor
April 14, 2026The Bank of Nova ScotiaShareholder Proposal Regarding Board Youth Representation Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalForAgainst

Search this fund’s votes by company

639 ballot items at 43 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, 1290 VT Equity Income Portfolio voted at 43 shareholder meetings of 43 companies, on 639 ballot items in all. Where management made a recommendation, the fund followed it on 94.5% of the items and voted against it 34 times. Its most frequent area of disagreement was corporate governance (10 of its votes against management). It voted on 34 shareholder proposals. It voted FOR the board's own proposals more often than Equitable's funds as a whole (93.6% against 92.5%). It voted differently from most Equitable funds on 29 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.